Today, the Tenth Circuit Court of Appeals rejected Defendants’ bid to appeal the district court’s class certification order for a nationwide RICO class in In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, the multidistrict litigation against Mylan and Pfizer that seeks to hold Defendants accountable for forcing consumers to pay inflated prices for EpiPens. Today’s order allows the class action to move forward toward trial, which is scheduled for April 2021.
Keller Rohrback L.L.P. is pleased to announce that Honorable Mark L. Wolf of the United States District Court of Massachusetts has approved a $300 million settlement between plaintiffs and State Street Bank and Trust Company (SBBT).
